Radiation oncologist · National Cancer Center Tokyo · Japan (JP) · Oncology
Data minimisation
Cadence target for Tier 2: 2 per year (assumption)
1 of 1 expected engagements
No insights captured from engagements with this stakeholder.
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 22 Jul 2026 | Scientific exchange | In person | Rachel Adeyemi | Vantrexa | Comparator checkpoint monotherapyPD-L1 testing turnaround | 0 | — | Reviewed | ENG-0029 |
22 Jul 2026
Comparator checkpoint monotherapy, PD-L1 testing turnaround
National Cancer Center Tokyo
Oncology pharmacist
Oncology pharmacist
Primary care physician
Headache specialist